First Time Loading...
P

Purple Biotech Ltd
NASDAQ:PPBT

Watchlist Manager
Purple Biotech Ltd
NASDAQ:PPBT
Watchlist
Price: 0.5127 USD 4.63% Market Closed
Updated: Apr 25, 2024
Section:
 

Intrinsic Value

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of PPBT.

Key Points:
PPBT Intrinsic Value
Base Case
Not Available
P
Base Case Scenario
What is intrinsic value?

Fundamental Analysis

Beta
Ask me anything about
Purple Biotech Ltd

What unique competitive advantages
does Purple Biotech Ltd hold over its rivals?

What risks and challenges
does Purple Biotech Ltd face in the near future?

Provide an overview of the primary business activities
of Purple Biotech Ltd.

Show me price targets
for Purple Biotech Ltd made by professional analysts.

Provide an overview of the primary business activities
of Purple Biotech Ltd.

What unique competitive advantages
does Purple Biotech Ltd hold over its rivals?

What risks and challenges
does Purple Biotech Ltd face in the near future?

Show all valuation multiples
for Purple Biotech Ltd.

Provide P/S
for Purple Biotech Ltd.

Provide P/E
for Purple Biotech Ltd.

Provide P/OCF
for Purple Biotech Ltd.

Provide P/FCFE
for Purple Biotech Ltd.

Provide P/B
for Purple Biotech Ltd.

Provide EV/S
for Purple Biotech Ltd.

Provide EV/GP
for Purple Biotech Ltd.

Provide EV/EBITDA
for Purple Biotech Ltd.

Provide EV/EBIT
for Purple Biotech Ltd.

Provide EV/OCF
for Purple Biotech Ltd.

Provide EV/FCFF
for Purple Biotech Ltd.

Provide EV/IC
for Purple Biotech Ltd.

Show me price targets
for Purple Biotech Ltd made by professional analysts.

What are the Revenue projections
for Purple Biotech Ltd?

How accurate were the past Revenue estimates
for Purple Biotech Ltd?

What are the Net Income projections
for Purple Biotech Ltd?

How accurate were the past Net Income estimates
for Purple Biotech Ltd?

What are the EPS projections
for Purple Biotech Ltd?

How accurate were the past EPS estimates
for Purple Biotech Ltd?

What are the EBIT projections
for Purple Biotech Ltd?

How accurate were the past EBIT estimates
for Purple Biotech Ltd?

Compare the revenue forecasts
for Purple Biotech Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Purple Biotech Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Purple Biotech Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Purple Biotech Ltd compared to its peers.

Compare the P/E ratios
of Purple Biotech Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Purple Biotech Ltd with its peers.

Analyze the financial leverage
of Purple Biotech Ltd compared to its main competitors.

Show all profitability ratios
for Purple Biotech Ltd.

Provide ROE
for Purple Biotech Ltd.

Provide ROA
for Purple Biotech Ltd.

Provide ROIC
for Purple Biotech Ltd.

Provide ROCE
for Purple Biotech Ltd.

Provide Gross Margin
for Purple Biotech Ltd.

Provide Operating Margin
for Purple Biotech Ltd.

Provide Net Margin
for Purple Biotech Ltd.

Provide FCF Margin
for Purple Biotech Ltd.

Show all solvency ratios
for Purple Biotech Ltd.

Provide D/E Ratio
for Purple Biotech Ltd.

Provide D/A Ratio
for Purple Biotech Ltd.

Provide Interest Coverage Ratio
for Purple Biotech Ltd.

Provide Altman Z-Score Ratio
for Purple Biotech Ltd.

Provide Quick Ratio
for Purple Biotech Ltd.

Provide Current Ratio
for Purple Biotech Ltd.

Provide Cash Ratio
for Purple Biotech Ltd.

What is the historical Revenue growth
over the last 5 years for Purple Biotech Ltd?

What is the historical Net Income growth
over the last 5 years for Purple Biotech Ltd?

What is the current Free Cash Flow
of Purple Biotech Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Purple Biotech Ltd.

Popular Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Financials
Revenue
Operating Income
Net Income
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Balance Sheet Decomposition
Purple Biotech Ltd

44.3m
Assets
10.1m
Liabilities
44.3m
Assets
10.1m
Liabilities
Current Assets 15.8m
Cash & Short-Term Investments 15.4m
Other Current Assets 376k
Non-Current Assets 28.5m
PP&E 470k
Intangibles 28m
Current Liabilities 7.2m
Accounts Payable 4.2m
Accrued Liabilities 2.8m
Other Current Liabilities 188k
Non-Current Liabilities 2.9m
Long-Term Debt 163k
Other Non-Current Liabilities 2.7m
Efficiency

Earnings Waterfall
Purple Biotech Ltd

Revenue
0 USD
Operating Expenses
-22.3m USD
Operating Income
-22.3m USD
Other Expenses
2.4m USD
Net Income
-19.9m USD
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE

Free Cash Flow Analysis
Purple Biotech Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PPBT Profitability Score
Profitability Due Diligence

Purple Biotech Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Negative Operating Income
Negative Net Income
23/100
Profitability
Score

Purple Biotech Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

PPBT Solvency Score
Solvency Due Diligence

Purple Biotech Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
51/100
Solvency
Score

Purple Biotech Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PPBT Price Targets Summary
Purple Biotech Ltd

There are no price targets for PPBT.
PPBT Lowest Forecast
Wall Street Target
Not Available
PPBT Average Forecast
Wall Street Target
Not Available
PPBT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

PPBT Price
Purple Biotech Ltd

1M 1M
-16%
6M 6M
-66%
1Y 1Y
-71%
3Y 3Y
-86%
5Y 5Y
-95%
10Y 10Y
-66%
Annual Price Range
20.5
52w Low
18.1
52w High
78.7
Price Metrics
Average Annual Return -36.05%
Standard Deviation of Annual Returns 24.61%
Max Drawdown -96%
Shares Statistics
Market Capitalization 42.6m ILS
Shares Outstanding 2 078 738
Percentage of Shares Shorted
N/A

PPBT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Purple Biotech Ltd

Country

Israel

Industry

Pharmaceuticals

Market Cap

42.6m USD

Dividend Yield

0%

Description

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Contact

Rehovot
Oppenheimer 4
+97239333121.0
https://purple-biotech.com/

IPO

1978-09-03

Employees

13

Officers

Chief Executive Officer
Mr. Gil Efron CPA, M.A.
Head of Clinical & Regulatory Affairs
Dr. Michael Schickler Ph.D.
Chief Financial Officer
Mr. Lior Fhima CPA, M.B.A.
Vice President of Operations
Mr. Ido Morpurgo B.Sc., L.L.M.

See Also

Summary
PPBT intrinsic value, competitors valuation, and company profile.
DCF Valuation
PPBT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PPBT stock valuation using valuation multiples.
Wall Street Estimates
PPBT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PPBT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.